Lilly unveils more positive late-stage data for its once-weekly insulin

On Thursday, Eli Lilly dropped more data for its once-weekly insulin candidate in adults with type 2 diabetes.

In two Phase 3 trials, dubbed QWINT …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

The Importance of Empathy and Clarity in Healthcare Billin

Suman Chaudhuri, Vice President, CSG Forte When you leave the doctor, you’ll have a plan of care in hand. For instance, when you break an

December 21, 2023

Laser-based 3D bioprinting of corneas for vision restoration

Printing a new cornea during an operation to restore a patient’s eyesight: This groundbreaking step in the fight against corneal disorders is set to become

June 19, 2024

Daré’s royalty deal; Qlaris Bio raises $24M

Plus, news about Newron and SynOx: Daré Bioscience inks royalty deal with XOMA: The company received $22 million, which is expected to help progress a

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.